Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Salven

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Acta Haematologica|January 30, 2002
Angiogenesis in lymphoproliferative disordersP Salven
Blood|November 24, 1999
A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphomaP Salven, L Teerenhovi, H Joensuu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factorP Salven, A Orpana, H Joensuu
British Journal of Cancer|January 1, 1997
Enhanced expression of vascular endothelial growth factor in metastatic melanomaP Salven, P Heikkilä, H Joensuu
Blood|October 24, 1997
A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphomaP Salven, L Teerenhovi, H Joensuu
International Journal of Cancer|May 16, 1998
High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancerP Salven, T Ruotsalainen, K Mattson, et al.
Blood|November 23, 2000
Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patientsP Salven, A Orpana, L Teerenhovi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 5, 1997
Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significanceP Salven, P Heikkilä, A Anttonen, et al.
Breast Cancer Research and Treatment|May 18, 1999
Serum VEGF levels in women with a benign breast tumor or breast cancerP Salven, V Perhoniemi, H Tykkä, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Serum vascular endothelial growth factor is often elevated in disseminated cancerP Salven, H Mänpää, A Orpana, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Acta Haematologica|January 30, 2002
Angiogenesis in lymphoproliferative disordersP Salven
Blood|November 24, 1999
A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphomaP Salven, L Teerenhovi, H Joensuu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factorP Salven, A Orpana, H Joensuu
British Journal of Cancer|January 1, 1997
Enhanced expression of vascular endothelial growth factor in metastatic melanomaP Salven, P Heikkilä, H Joensuu
Blood|October 24, 1997
A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphomaP Salven, L Teerenhovi, H Joensuu
International Journal of Cancer|May 16, 1998
High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancerP Salven, T Ruotsalainen, K Mattson, et al.
Blood|November 23, 2000
Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patientsP Salven, A Orpana, L Teerenhovi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 5, 1997
Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significanceP Salven, P Heikkilä, A Anttonen, et al.
Breast Cancer Research and Treatment|May 18, 1999
Serum VEGF levels in women with a benign breast tumor or breast cancerP Salven, V Perhoniemi, H Tykkä, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Serum vascular endothelial growth factor is often elevated in disseminated cancerP Salven, H Mänpää, A Orpana, et al.
Pageof 2